Volume 41, Issue 2

Hematology and Cell Therapy is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites.

Search all Hematology and Cell Therapy articles

April 1999

11 articles in this issue

Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantation
J.Y. Cahn
E. Deconinck
P. Hervé
Original articles 16 February 2016 Pages: 31 - 37
Reticulocytes and solvents an epidemiological study
E. Cardoso
J.-P. Cazenave
F. Conso
Original articles 16 February 2016 Pages: 39 - 47
Evaluation of the monocyte counting by the ABX Vega. Comparison with the manual method and fluoro-flow cytometry
M. Morillon
J. Maslin
G. Martet
Original articles 16 February 2016 Pages: 47 - 50
Mécanismes de la progression des carcinomes
J.-P. Thiery
Original articles 16 February 2016 Pages: 51 - 55
Pre-clinical and early clinical experience using dendritic cells to treat human malignancy
L. Kanz
P. Brossart
W. Brugger
Original articles 16 February 2016 Pages: 56 - 57
High dose chemotherapy with haematopoietic rescue in breast cancer
W.R. Bezwoda
Original articles 16 February 2016 Pages: 58 - 65
Tumor cells in breast tumors: significance of their presence for prognosis
L. Edelman
J.-C. Durand
D. Sainty
Original articles 16 February 2016 Pages: 66 - 70
Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques (CSH) dans le traitement des cancers du sein métastatiques : résultats du programme national Pegase 04
J.-P. Lotz
H. Curé
C. Gisselbrecht
Original articles 16 February 2016 Pages: 71 - 74
Expansion ex-vivo des cellules hématopoïétiques : étude dans le modèle primate
F. Norol
M. Drouet
F. Herodin
Original articles 16 February 2016 Pages: 75 - 77
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell® technology
C. Chabannon
G. Novakovitch
P. Viens
Original articles 16 February 2016 Pages: 78 - 81
Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer
I. McNiece
R. Jones
E.J. Shpall
Original articles 16 February 2016 Pages: 82 - 86

Volume 41, Issue 2

Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantation

Reticulocytes and solvents an epidemiological study

Evaluation of the monocyte counting by the ABX Vega. Comparison with the manual method and fluoro-flow cytometry

Mécanismes de la progression des carcinomes

Pre-clinical and early clinical experience using dendritic cells to treat human malignancy

High dose chemotherapy with haematopoietic rescue in breast cancer

Tumor cells in breast tumors: significance of their presence for prognosis

Intensification thérapeutique et autogreffe de cellules souches hématopoïétiques (CSH) dans le traitement des cancers du sein métastatiques : résultats du programme national Pegase 04

Expansion ex-vivo des cellules hématopoïétiques : étude dans le modèle primate

The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell® technology

Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer

Navigation